| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 2.27▲ | 2.26▲ | 2.26▲ | 2.25▲ | 2.04▲ |
| MA10 | 2.27▲ | 2.26▲ | 2.26▲ | 2.16▲ | 2.14▲ |
| MA20 | 2.26▲ | 2.26▲ | 2.25▲ | 2.02▲ | 2.47▼ |
| MA50 | 2.26▲ | 2.23▲ | 2.19▲ | 2.18▲ | 2.06▲ |
| MA100 | 2.26▲ | 2.17▲ | 2.06▲ | 2.53▼ | 2.01▲ |
| MA200 | 2.22▲ | 2.04▲ | 2.08▲ | 2.14▲ | 4.50▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.002▲ | -0.001▼ | -0.004▼ | 0.047▲ | -0.069▼ |
| RSI | 56.059▲ | 58.888▲ | 63.415▲ | 56.616▲ | 50.061▲ |
| STOCH | 46.111 | 43.056 | 32.593 | 87.962▲ | 32.611 |
| WILL %R | -33.333 | -33.333 | -33.333 | -5.714▲ | -58.427 |
| CCI | 61.247 | 190.909▲ | 88.427 | 96.863 | -6.887 |
| CDL | $IKT Doji Candlestick Pattern Detected | Set Alert |
|
Friday, May 02, 2025 02:07 AM
Inhibikase (IKT) pivots to IkT-001Pro for PAH amid competition like Merck’s sotatercept. Backed by $97.5M, results will determine its future competitiveness. See more.
|
|
Tuesday, April 22, 2025 07:39 AM
This feature is currently unavailable; we are sorry for the inconvenience to you. Nasdaq Analyst Research provides analyst research for ratings consensus and a summary of stock price targets.
|
|
Monday, April 14, 2025 05:24 AM
Inc. (Nasdaq: IKT) (“Inhibikase” or“Company”), a clinical-stage pharmaceutical company innovating small molecule kinase inhibitor therapeutics to treat pulmonary arterial hypertension ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 02/05/25 | 2.28 | 2.30 | 2.25 | 2.28 | 9,332 |
| 01/05/25 | 2.26 | 2.31 | 2.21 | 2.24 | 49,845 |
| 30/04/25 | 2.17 | 2.295 | 2.155 | 2.26 | 131,592 |
| 29/04/25 | 2.15 | 2.26 | 2.14 | 2.25 | 125,050 |
| 28/04/25 | 2.15 | 2.20 | 2.09 | 2.20 | 136,608 |
| 25/04/25 | 2.22 | 2.23 | 2.095 | 2.11 | 93,404 |
| 24/04/25 | 2.15 | 2.26 | 2.11 | 2.26 | 103,590 |
| 23/04/25 | 2.02 | 2.175 | 2.01 | 2.16 | 112,002 |
| 22/04/25 | 1.93 | 1.965 | 1.785 | 1.96 | 131,002 |
| 21/04/25 | 1.85 | 1.90 | 1.79 | 1.89 | 62,382 |
|
|
||||
|
|
||||
|
|